SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51228It's stated right on the trial page. ESRD on stable dialysis. Is their ESRsemi_infinite 111/13/2019
51227Please, can somebody confirm...is Blackrock that big? 2.46 T $ ? old.nasdaq.comMiljenko Zuanic-11/13/2019
51226Where is written that it is cohort(s) and stage5 (end-stage)? It is STABLE DD CMiljenko Zuanic111/13/2019
51225sorry i can't answer you because i have trouble remembering pyrenees,alps ..linhtu-11/13/2019
51224Were they discussing the Pyrenees trial? That would provide a benign interpretaA.J. Mullen-11/13/2019
51223Cohorts are all stage 5 for Pyrenees so why would FDA want to mix the data up? semi_infinite -11/13/2019
51222Make that 7 organizations since FDA didn't want Pyrenees data mixed into jussemi_infinite -11/13/2019
51221fgen : has anyone actually listened to the QA section of Azn call where the PIs linhtu311/13/2019
51220Glad to hear you find it useful. Twitter is helpful when trying to get the 'bmaz001-11/13/2019
51219Thanks, that's useful to me. I've read Dew's board on InvestorHub. A.J. Mullen-11/13/2019
51218If anyone is interested in getting lost in the recent FGEN-related Twitter traffbmaz001111/13/2019
51217FGEN/AZN - It was nice to see this in my Twitter feed this morning. [graphic]bmaz001311/13/2019
51216[graphic]IRWIN JAMES FRANKEL-11/13/2019
51215Interesting study on the prevalence of bacteriophage in various human body fluidnigel bates111/13/2019
51214RE: Pyrenees (EU, data) clinicaltrialsregister.eu TEAEs are problematic for RoMiljenko Zuanic211/12/2019
51213What makes sense to me is what matters is whether AstraZeneca believes the roxa BulbaMan311/12/2019
51212You guys appear to be making sense of some of the FGEN confusion over on Dew'bmaz001-11/12/2019
51211The 10-Q says: "The below cardiovascular safety analyses reflect the poolimouton29111/12/2019
51210It seems clear that the FDA agreed to the pooling analysis, i.e., to the exclusiDaveAu-11/12/2019
51209I just listened again to the beginning of Dr. Yu's presentation: she said thA.J. Mullen211/12/2019
51208There's no fraud as the Pyrenees study is publicly reported and discussed inmouton29111/12/2019
51207IMO shorts have a positive role to play if they expose fraud. However, in this semi_infinite -11/12/2019
51206Funny. I can see how you'd think I'm short given that I keep broadcastinbmaz001-11/12/2019
51205Then it is up to the shorts to come up with the "something". Zilch sosemi_infinite -11/12/2019
51204I bought Jan2021C40 I figure that by then Azn would have bought fgen already. linhtu-11/12/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News